DAZATRO

Serial Number 99034925
688

Registration Progress

Application Filed
Feb 10, 2025
Under Examination
Jul 1, 2025
Approved for Publication
May 6, 2025
Published for Opposition
May 6, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jan 01, 2026 152 days

Trademark Image

DAZATRO

Basic Information

Serial Number
99034925
Filing Date
February 10, 2025
Published for Opposition
May 6, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Jul 1, 2025
Application
Pending
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG12NY
GB

Ownership History

Glaxo Group Limited

Original Applicant
99
Stevenage GB

Glaxo Group Limited

Owner at Publication
99
Stevenage GB

Legal Representation

Attorney
Elizabeth K. Rucki

USPTO Deadlines

Next Deadline
152 days remaining
NOA E-Mailed - SOU Required
Due Date
January 01, 2026
Extension Available
Until July 01, 2026

Application History

9 events
Date Code Type Description Documents
Jul 1, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 6, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 6, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 30, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 4, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 8, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 10, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 10, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 10, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Classification

International Classes
005